Search Results - Youssefian, Leena E

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Circumvention of Mcl-1-dependent drug resistance by simultaneous Chk1 and MEK1/2 inhibition in human multiple myeloma cells

    Circumvention of Mcl-1-dependent drug resistance by simultaneous Chk1 and MEK1/2 inhibition in human multiple myeloma cells by Pei, Xin-Yan, Dai, Yun, Felthousen, Jessica, Chen, Shuang, Takabatake, Yukie, Zhou, Liang, Youssefian, Leena E, Sanderson, Michael W, Bodie, Wesley W, Kramer, Lora B, Orlowski, Robert Z, Grant, Steven

    Published in PloS one
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Cytokinetically quiescent (G0/G1) human multiple myeloma cells are susceptible to simultaneous inhibition of Chk1 and MEK1/2

    Cytokinetically quiescent (G0/G1) human multiple myeloma cells are susceptible to simultaneous inhibition of Chk1 and MEK1/2 by Pei, Xin-Yan, Dai, Yun, Youssefian, Leena E., Chen, Shuang, Bodie, Wesley W., Takabatake, Yukie, Felthousen, Jessica, Almenara, Jorge A., Kramer, Lora B., Dent, Paul, Grant, Steven

    Published in Blood
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Erratum to: Phase I trial of bortezomib and dacarbazine in melanoma and soft tissue sarcoma

    Erratum to: Phase I trial of bortezomib and dacarbazine in melanoma and soft tissue sarcoma by Poklepovic, Andrew, Youssefian, Leena E., Winning, Mary, Birdsell, Christine A., Crosby, Nancy A., Ramakrishnan, Viswanathan, Ernstoff, Marc S., Roberts, John D.

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Bcl-2 Antagonism Potentiates MEK1/2/Chk1 Inhibitor Lethality in Multiple Myeloma Cells Overexpressing Bcl-2 through a Stat3-Dependent Mechanism

    Bcl-2 Antagonism Potentiates MEK1/2/Chk1 Inhibitor Lethality in Multiple Myeloma Cells Overexpressing Bcl-2 through a Stat3-Dependent Mechanism by Pei, Xin-Yan, Sanderson, Michael W, Youssefian, Leena E, Felthousen, Jessica, Kramer, Lora B, Dai, Yun, Grant, Steven

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Abstract 3390: Simultaneous Chk1 and MEK1/2 inhibition circumvents Mcl-1-mediated anti-apoptotic functions and bortezomib resistance in human multiple myeloma cells

    Abstract 3390: Simultaneous Chk1 and MEK1/2 inhibition circumvents Mcl-1-mediated anti-apoptotic functions and bortezomib resistance in human multiple myeloma cells by Pei, Xin-Yan, Dai, Yun, Felthousen, Jessica, Chen, Shuang, Takabatake, Yukie, Youssefian, Leena E., Bodie, Wesley W., Kramer, Lora B., Orlowski, Robert Z., Grant, Steven

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Phase I trial of bortezomib and dacarbazine in melanoma and soft tissue sarcoma

    Phase I trial of bortezomib and dacarbazine in melanoma and soft tissue sarcoma by Poklepovic, Andrew, Youseffian, Leena, Winning, Mary, Birdsell, Christine A., Crosby, Nancy A., Ramakrishnan, Viswanathan, Ernstoff, Marc S., Roberts, John D.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Abstract 4667: Simultaneous Chk1 and MEK1/2 inhibition circumvents Mcl-1 anti-apoptotic function and bortezomib resistance in human multiple myeloma cells

    Abstract 4667: Simultaneous Chk1 and MEK1/2 inhibition circumvents Mcl-1 anti-apoptotic function and bortezomib resistance in human multiple myeloma cells by Pei, Xin-Yan, Dai, Yun, Felthousen, Jessica, Chen, Shuang, Wang, Li, Takabatake, Yukie, Youssefian, Leena E., Bodie, Wesley W., Kramer, Lora, Grant, Steven

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Abstract 5367: Simultaneous inhibition of Chk1 and MEK1/2 targets non-proliferating multiple myeloma cells

    Abstract 5367: Simultaneous inhibition of Chk1 and MEK1/2 targets non-proliferating multiple myeloma cells by Pei, Xin-Yan, Dai, Yun, Youssefian, Leena E., Chen, Shuang, Bodie, Wesley, Takabatake, Yukie, Almenara, George, Kramer, Lora, Dent, Paul, Grant, Steven

    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Cytokinetically quiescent (G0/G1) human multiple myeloma cells are susceptible to simultaneous inhibition of Chkl and MEK1/2

    Cytokinetically quiescent (G0/G1) human multiple myeloma cells are susceptible to simultaneous inhibition of Chkl and MEK1/2 by PEI, Xin-Yan, YUN DAI, GRANT, Steven, YOUSSEFIAN, Leena E, SHUANG CHEN, BODIE, Wesley W, TAKABATAKE, Yukie, FELTHOUSEN, Jessica, ALMENARA, Jorge A, KRAMER, Lora B, DENT, Paul

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Circumvention of Mcl-1-Dependent Drug Resistance by Simultaneous Chk1 and MEK1/2 Inhibition in Human Multiple Myeloma Cells: e89064

    Circumvention of Mcl-1-Dependent Drug Resistance by Simultaneous Chk1 and MEK1/2 Inhibition in Human Multiple Myeloma Cells: e89064 by Pei, Xin-Yan, Dai, Yun, Felthousen, Jessica, Chen, Shuang, Takabatake, Yukie, Zhou, Liang, Youssefian, Leena E, Sanderson, Michael W, Bodie, Wesley W, Kramer, Lora B

    Published in PloS one
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: